Urdaneta v. Keeton

CourtDistrict Court, D. Arizona
DecidedMay 11, 2020
Docket2:20-cv-00654
StatusUnknown

This text of Urdaneta v. Keeton (Urdaneta v. Keeton) is published on Counsel Stack Legal Research, covering District Court, D. Arizona primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Urdaneta v. Keeton, (D. Ariz. 2020).

Opinion

1 MW 2 WO 3 4 5 6 IN THE UNITED STATES DISTRICT COURT 7 FOR THE DISTRICT OF ARIZONA 8

No. CV-20-00654-PHX-SPL (JFM) 9 Jhonnatan Brinez Urdaneta, et al.,

10 Petitioners-Plaintiffs, ORDER v. 11 12 Chuck Keeton, et al., 13 Respondents-Defendants. 14

15 Petitioners-Plaintiffs have filed, through counsel, a Petition for Writ of Habeas 16 Corpus under 28 U.S.C. § 2241 and Complaint for Injunctive and Declaratory Relief 17 (Doc. 1) and an Application for Temporary Restraining Order and Order to Show Cause 18 Regarding Preliminary Injunction (Doc. 19), seeking their immediate release from custody 19 due to the health risks associated with the spread of COVID-19 in CoreCivic’s La Palma 20 Correctional Center and Eloy Detention Center. This matter has been fully briefed, and as 21 follows, the Petition will be granted in part.1 22 I. Background 23 A. Coronavirus Disease 2019 (“COVID-19”) 24 COVID-19, a disease caused by a novel strain of coronavirus (SARS-CoV-2), was 25 declared by the World Health Organization as a global pandemic on March 11, 2020. As 26 of the date of this Order, in the United States, 1,334,951 individuals have been confirmed 27 28 1 Neither party has requested oral argument, and the Court finds this matter suitable for decision as submitted on the briefs without a hearing. See LRCiv 16.1(e). 1 as positive for COVID-19, of which 11,383 have been confirmed positive in Arizona.2 2 The United States Department of Health and Human Services Centers for Disease 3 Control and Prevention (“CDC”) reports that individuals who contract and transmit 4 COVID-19 experience symptoms that range from negligible, with some individuals 5 remaining entirely asymptomatic, to mild, such as fever, coughing, and difficulty 6 breathing, to severe, including acute respiratory distress, severe pneumonia, septic shock, 7 and multi-organ failure, or even death.3 The CDC estimates that serious illness or death 8 occurs in 16% of all cases.4 Those at high-risk of suffering severe illness or death from 9 COVID-19 include individuals who are 65 years and older, or individuals of any age with 10 underlying medical conditions including chronic lung disease, moderate to severe asthma, 11 a serious heart condition, a weakened immune system, severe obesity, diabetes, chronic 12 kidney disease, or liver disease.5 13 The virus that causes COVID-19 “is thought to spread mainly through close contact 14 from person-to-person in respiratory droplets from someone who is infected.”6 The 15 incubation period for COVID-19 extends 14 days on average, with a median time of 4-5 16 days from exposure to symptoms onset.7 The CDC recommends that to avoid exposure 17 and transmission, the public should maintain a physical distance of at least six feet from 18 others, wear cloth face covers, frequently wash hands or use hand sanitizer, and disinfect 19 frequently touched surfaces.8 High-risk individuals should take additional “special

20 2 Coronavirus Resource Center: COVID-19 Dashboard, Johns Hopkins Univ. & Med., https://coronavirus.jhu.edu/map.html (last accessed May 11, 2020). 21 3 CDC Interim Clinical Guidance for Management of Patients with Confirmed 22 Coronavirus Disease (COVID-19), https://www.cdc.gov/coronavirus/2019-ncov/hcp/clini cal-guidance-management-patients.html (last accessed May 11, 2020). 23 4 CDC Situation Summary, https://www.cdc.gov/coronavirus/2019-ncov/summary. html (last accessed May 11, 2020). 24 5 CDC People Who Are at Higher Risk for Severe Illness, https://www.cdc.gov/cor 25 onavirus/2019-ncov/need-extra-precautions/people-at-higher-risk.html (last accessed May 11, 2020). 26 6 CDC How COVID-19 Spreads, https://www.cdc.gov/coronavirus/2019-ncov/pre vent-getting-sick/how-covid-spreads.html (last accessed May 11, 2020). 27 7 See n.3, supra. 28 8 CDC How to Protect Yourself & Others, https://www.cdc.gov/coronavirus/2019- ncov/prevent-getting-sick/prevention.html (last accessed May 11, 2020). 1 precautions,” such as continue active treatment of their underlying medical conditions, 2 obtain vaccinations against other diseases like influenza and pneumococcal illness, stay 3 home, and remain away from others “as much as possible.”9 4 B. Detention Facility COVID-19 Guidance 5 On March 23, 2020, the CDC issued an “Interim Guidance on Management of 6 Coronavirus Disease 2019 (COVID-19) in Correctional and Detention Facilities” (“CDC 7 Guidance”)10 which “provides interim guidance specific for correctional facilities and 8 detention centers during the outbreak of COVID-19, to ensure continuation of essential 9 public services and protection of the health and safety of incarcerated and detained persons, 10 staff, and visitors.” (CDC Guidance at 2.) The guidance reports there is a heightened risk 11 of transmission of COVID-19 to and among individuals within detention facilities due to, 12 among other things, the number of sources which can introduce them into a facility’s 13 population, including detention staff, visitors, contractors, vendors, legal representatives, 14 court staff, and new detainees; the congregate environment in which detainees “live, work, 15 eat, study, and recreate”; and limited medical isolation options, hygiene supplies, and 16 dissemination of accurate information among detainees. (CDC Guidance at 2.)11 For those 17 reasons, the guidance recommends that detention facilities implement specific measures to 18 prepare for potential transmission of COVID-19, to prevent the spread of COVID-19, and 19 to manage confirmed and suspected COVID-19 cases to prevent further transmission and 20 provide treatment. 21 The guidance states that “[a]lthough social distancing is challenging to practice in 22 correctional and detention environments, it is a cornerstone of reducing transmission of 23 9 CDC Groups at Higher Risk for Severe Illness, https://www.cdc.gov/coronavirus 24 /2019-ncov/need-extra-precautions/groups-at-higher-risk.html (last accessed May 11, 2020). 25 10 CDC Interim Guidance on Management of Coronavirus Disease 2019 (COVID- 26 19) in Correctional and Detention Facilities, https://www.cdc.gov/coronavirus/2019-nco v/downloads/guidance-correctional-detention.pdf (last accessed May 11, 2020). 27 11 “People in correctional and detention facilities are at greater risk for some illnesses, such as COVID-19.” CDC FAQs for Correctional and Detention Facilities, http 28 s://www.cdc.gov/coronavirus/2019-ncov/community/correction-detention/faq.html#Peopl e (last accessed May 11, 2020). 1 respiratory diseases such as COVID-19.” (CDC Guidance at 4.) It recommends 2 implementing social distancing strategies to increase the physical space between detained 3 persons “(ideally 6 feet between all individuals, regardless of the presence of symptoms),” 4 such as increasing space between individuals in cells, increasing space between individuals 5 in lines and waiting areas; choosing recreation spaces where individuals can spread out and 6 staggering time in those spaces; staggering meals and rearrange seating in the dining hall 7 so that there is more space between individuals; providing meals inside housing units or 8 cells; limiting the size of group activities and increasing space between individuals during 9 group activities. (Id. at 4, 11.) It further recommends that facilities should house 10 quarantined individuals who have had close contact with a COVID-19 case, or individuals 11 in medical isolation who are suspected or confirmed positive with COVID-19, in order of 12 preference, separately in single cells or as a cohort, although “[c]ohorting should only be 13 practiced if there are no other available options.” (Id. at 15-20.)12 “If cohorting is 14 unavoidable, [facilities should] make all possible accommodations to reduce exposure risk 15 for the higher-risk individuals.” (Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Preiser v. Rodriguez
411 U.S. 475 (Supreme Court, 1973)
Paul v. Davis
424 U.S. 693 (Supreme Court, 1976)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Bell v. Wolfish
441 U.S. 520 (Supreme Court, 1979)
Allen v. McCurry
449 U.S. 90 (Supreme Court, 1980)
Youngberg v. Romeo Ex Rel. Romeo
457 U.S. 307 (Supreme Court, 1982)
Whitley v. Albers
475 U.S. 312 (Supreme Court, 1986)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Helling v. McKinney
509 U.S. 25 (Supreme Court, 1993)
Demore v. Kim
538 U.S. 510 (Supreme Court, 2003)
Muhammad v. Close
540 U.S. 749 (Supreme Court, 2004)
Nelson v. Campbell
541 U.S. 637 (Supreme Court, 2004)
Hill v. McDonough
547 U.S. 573 (Supreme Court, 2006)
DaimlerChrysler Corp. v. Cuno
547 U.S. 332 (Supreme Court, 2006)
Hein v. Freedom From Religion Foundation, Inc.
551 U.S. 587 (Supreme Court, 2007)
Boumediene v. Bush
553 U.S. 723 (Supreme Court, 2008)
Munaf v. Geren
553 U.S. 674 (Supreme Court, 2008)
United States v. Lissette Christina Nukida
8 F.3d 665 (Ninth Circuit, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
Urdaneta v. Keeton, Counsel Stack Legal Research, https://law.counselstack.com/opinion/urdaneta-v-keeton-azd-2020.